BackDefinium Therapeutics Overview

Definium Therapeutics Minority Interest

Definium Therapeutics's minority interest is $0.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer average

Loading

Definium Therapeutics Minority Interest History

Loading

Definium Therapeutics vs. peers: Minority Interest Comparison

Loading

Definium Therapeutics Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Definium Therapeutics (DFTX) FAQ

Definium Therapeutics (DFTX) currently reports a minority interest of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Definium Therapeutics's minority interest history and peer comparisons.

Definium Therapeutics's minority interest changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Definium Therapeutics reported $0 in minority interest as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Definium Therapeutics, and consider following DFTX for alerts when major investors trade the stock.

Definium Therapeutics is classified in the Healthcare sector. On minority interest, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DFTX with unrelated industries.